Abstract
Pigs have been recognized as an excellent biomedical model for investigating a variety of human health issues. We developed genetically modified pigs that exhibit the apparent symptoms of diabetes. Transgenic cloned pigs carrying a mutant human hepatocyte nuclear factor 1α gene, which is known to cause the type 3 form of maturity-onset diabetes of the young, were produced using a combined technology of intracytoplasmic sperm injection-mediated gene transfer and somatic cell nuclear transfer. Although most of the 22 cloned offspring obtained died before weaning, four pigs that lived for 20–196 days were diagnosed as diabetes mellitus with nonfasting blood glucose levels greater than 200 mg/dl. Oral glucose tolerance test on a cloned pig also revealed a significant increase of blood glucose level after glucose loading. Histochemical analysis of pancreas tissue from the cloned pigs showed small and irregularly formed Langerhans Islets, in which poor insulin secretion was detected.
Similar content being viewed by others
References
Frischmeyer PA, Dietz HC (1999) Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8:1893–1900. doi:10.1093/hmg/8.10.1893
Hagenfeldt-Johansson KA, Herrera PL, Wang H, Gjinovci A, Ishihara H, Wollheim CB (2001) β-Cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1α induces a maturity-onset diabetes of the young (MODY) 3-like phenotype in transgenic mice. Endocrinology 142:5311–5320. doi:10.1210/en.142.12.5311
Harries LW, Hattersley AT, Ellard S (2004) Messenger RNA transcripts of the hepatocyte nuclear factor-1α gene containing premature termination codons are subject to nonsense-mediated decay. Diabetes 53:500–504. doi:10.2337/diabetes.53.2.500
Higgins PJ, Garlick RL, Bunn HF (1982) Glycosylated hemoglobin in human and animal red cells. Role of glucose permeability. Diabetes 31:743–748. doi:10.2337/diabetes.31.9.743
Iwasaki N, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Yano N, Iwamoto Y (1998) Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Diabetes Care 21:2144–2148. doi:10.2337/diacare.21.12.2144
Kawarasaki T, Kohsaka T, Sone M, Yoshida M, Bamba K (1995) Detection of Y-bearing porcine spermatozoa by in situ hybridization using digoxigenin-labeled, porcine male-specific DNA probe produced by polymerase chain reaction. Mol Reprod Dev 40:455–459. doi:10.1002/mrd.1080400409
Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Ålerblom HK (2005) Enviromental triggers and determinants of type 1 diabetes. Diabetes 54:S125–S136. doi:10.2337/diabetes.54.suppl_2.S125
Kurome M, Ueda H, Tomii R, Naruse K, Nagashima H (2006) Production of transgenic-clone pigs by the combination of ICSI-mediated gene transfer with somatic cell nuclear transfer. Transgenic Res 15:229–240. doi:10.1007/s11248-006-0004-5
Kurome M, Saito H, Tomii R, Ueno S, Hiruma K, Nagashima H (2007) Effects of sperm petreatment of on efficiency of ICSI-mediated gene transfer in pigs. J Reprod Dev 53:1217–1226. doi:10.1262/jrd.19069
Kurome M, Hisatomi H, Matsumoto S, Tomii R, Ueno S, Hiruma K, Saito H, Nakamura K, Okumura K, Matsumoto M, Kaji Y, Endo F, Nagashima H (2008) Production efficiency and telomere length of the cloned pigs following serial somatic cell nuclear transfer. J Reprod Dev 54:254–258. doi:10.1262/jrd.20038
Larsen MO, Rolin B (2004) Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 45:303–313
Larsen MO, Wilken M, Gotfredsen CF, Carr RD, Svendsen O, Rolin B (2002) Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 282:E1342–E1351
Lunney JK (2007) Advances in swine biomedical model genomics. Int J Biol Sci 3:179–184
Mahimainathan L, Das F, Venkatesan B, Choudhury GG (2006) Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Diabetes 55:2115–2125. doi:10.2337/db05-1326
Miquerol L, Lopez S, Cathalie N, Tulliez M, Raymondjean M, Kahn A (1994) Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem 269:8944–8951
Murakami H, Matsumoto M, Inoue H, Kaji Y (2007) Digestive enzyme activities of pancreas and intestinal digesta in streptozotocin-induced diabetic piglets. Anim Sci J 78:55–60. doi:10.1111/j.1740-0929.2006.00404.x
Nicosia A, Monaci P, Tomei L, De Francesco R, Nuzzo M, Stunnenberg H, Cortese R (1990) A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 61:1225–1236. doi:10.1016/0092-8674(90)90687-A
Park M, Cho S, Lee S, Choi Y, Park J, Kwon D, Son W, Paik S, Kim T, Han Y, Kim J (2005) A rare and often unrecognized cerebromeningitis and hemodynamic disorder: a major cause of sudden death in somatic cell cloned piglets. Proteomics 5:1928–1939. doi:10.1002/pmic.200401079
Petters RM, Wells KD (1993) Culture of pig embryos. J Reprod Fertil Suppl 48:61–73
Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M (1996) Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal fanconi syndrome. Cell 84:575–585. doi:10.1016/S0092-8674(00)81033-8
Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS (1998) Defective insulin secretion in hepatocyte nuclear factor 1α-dedicient mice. J Clin Invest 101:2215–2222. doi:10.1172/JCI2548
Prather RS, Hawley RJ, Carter DB, Lai L, Greenstein JL (2003) Transgenic swine for biomedicine and agriculture. Theriogenology 59:115–123. doi:10.1016/S0093-691X(02)01263-3
Taylor KD, Norris JM, Rotter JI (2007) Genome-wide association. Which do you want first: the good news, the bad news, or the good news? Diabetes 56:2844–2848. doi:10.2337/db07-1324
Thomas H, Lemm I, Lausen J, Kind L, Roosen S, Ellard S, Hattersley AT, Ryffel GU (2002) Evidence for haploinsuffieciency of the human HNF1α gene revealed by functional characterization of MODY3-associated mutations. Biol Chem 383:1691–1700. doi:10.1515/BC.2002.190
Tuomi T (2005) Type 1 and type 2 diabetes. What do they have in common? Diabetes 54:S40–S45. doi:10.2337/diabetes.54.suppl_2.S40
Vaxillaire M, Abderrahmani A, Boutin P, Bailleul B, Froguel P, Yaniv M, Pontoglio M (1999) Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem 274:35639–35646. doi:10.1074/jbc.274.50.35639
Wang H, Antinozzi PA, Hagenfeldt KA, Maechler P, Wollheim CB (2000) Molecular targets of a human HNF1α mutation responsible for pancreatic β-cell dysfunction. EMBO J 19:4257–4264. doi:10.1093/emboj/19.16.4257
Watanabe M, Umeyama K, Kawano H, Izuno N, Nagashima H, Miki K (2007) The production of a diabetic mouse using constructs encoding porcine insulin promoter-driven mutant human hepatocyte nuclear factor-1α. J Reprod Dev 53:189–200. doi:10.1262/jrd.18068
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes. Diabetes Care 27:1047–1053. doi:10.2337/diacare.27.5.1047
Yamagata K (2003) Regulation of pancreatic β-cell function by the HNF transcription network: lesson from maturity-onset diabetes of the young (MODY). Endocr J 50:491–499. doi:10.1507/endocrj.50.491
Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj V, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chèvre J, Froguel P, Bell GI (1996) Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384:455–458. doi:10.1038/384455a0
Yamagata K, Yang Q, Yamamoto K, Iwahashi H, Miyagawa J, Okita K, Yoshiuchi I, Miyazaki J, Noguchi T, Nakajima H, Namba M, Hanafusa T, Matsuzawa Y (1998) Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative. Diabetes 47:1231–1235. doi:10.2337/diabetes.47.8.1231
Yamagata K, Nammo T, Moriwaki M, Ihara A, Iizuka K, Yang Q, Satoh T, Li M, Uenaka R, Okita K, Iwahashi H, Zhu Q, Cao Y, Imagawa A, Tochino Y, Hanafusa T, Miyagawa J, Matsuzawa Y (2002) Overexpression of dominant-negative mutant hepatocyte nuclear factor-1α in pancreatic β-cells cause abnormal islet architecture with decreased expression of E-cadherin, reduced β-cell proliferation, and diabetes. Diabetes 51:114–123. doi:10.2337/diabetes.51.1.114
Yamanouchi T, Minoda S, Yabuuchi M, Akanuma Y, Akanuma H, Miyashita H, Akaoka I (1989) Plasma 1, 5-anhydro-d-glucitol as new clinical marker of glycemic control in NIDDM patients. Diabetes 38:723–729. doi:10.2337/diabetes.38.6.723
Yamanouchi T, Moromizato H, Shinohara T, Minoda S, Miyashita H, Akaoka I (1992) Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1, 5 anhydroglucitol. Metabolism 41:862–867. doi:10.1016/0026-0495(92)90168-A
Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, Akaoka L, Miyashita H (1996) Clinical usefulness of plasma 1,5-anhydroglucitol in monitoring glycemic control. Lancet 347:1514–1518. doi:10.1016/S0140-6736(96)90672-8
Yin XJ, Tani T, Yonemura I, Kawakami M, Miyamoto K, Hasegawa R, Kato Y, Tsunoda Y (2002) Production of cloning pigs fromadult somatic cells by chemically assisted nemoval of maternal chromosomes. Biol Reprod 67:442–446. doi:10.1095/biolreprod67.2.442
Acknowledgments
This work was supported by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN), Tokyo, and Japan Science Technology Agency, ERATO, Nakauchi Stem Cell and Organ Regeneration Project, Tokyo. We thank K. Urakami for useful suggestion and R. Ohnishi and T. Okada for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Umeyama, K., Watanabe, M., Saito, H. et al. Dominant-negative mutant hepatocyte nuclear factor 1α induces diabetes in transgenic-cloned pigs. Transgenic Res 18, 697–706 (2009). https://doi.org/10.1007/s11248-009-9262-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11248-009-9262-3